Matsuda Hospital

Shizuoka 432-8061

1 studies enrolling now · 3 studies all time

What they study most

Fistulizing Crohns Disease, Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis, Perianal Crohns Disease

Studies at this site

• A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease — Running, not enrolling
• A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling